Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,084 public trials 2,045 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

NCT01732861

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Clearview Cancer Institute Oncology Specialties, P.C Huntsville, Alabama, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Mount Sinai School of Medicine New York, United States
View Trial Details
Completed

Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

NCT00364923

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
View all 32 locations
View Trial Details
Completed

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

NCT01134341

Conditions
Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT01578707

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +27 more
Locations
  • Site #408 La Jolla, California, United States
  • Site #377 Los Angeles, California, United States
  • Site #403 Santa Maria, California, United States
  • Site #038 Stanford, California, United States
View all 76 locations
View Trial Details
Completed

A Study of Fibrocaps™ in Surgical Bleeding

NCT01527357

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cardio-Thoracic Surgeons, PC Birmingham, Alabama, United States
  • University of Southern California, Keck School of Medicine Los Angeles, California, United States
  • University of Southern California/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 48 locations
View Trial Details
Completed

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

NCT01445379

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +31 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions